Increased prevalence of non-alcoholic fatty liver disease in European women with a history of gestational diabetes

Diabetologia

Volumn 54, Issue 3, 2011, Pages 641-647

  Forbes, S ^a   Taylor Robinson, S D ^b   Patel, N ^b   Allan, P ^c   Walker, B R ^a   Johnston, D G ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

Alanine transaminase; Gestational diabetes; Insulin sensitivity; Non alcoholic fatty liver disease; Type 2 diabetes

Indexed keywords

FATTY ACID; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ANTHROPOMETRY; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DIET RESTRICTION; DYSLIPIDEMIA; ECHOGRAPHY; EUROPE; FEMALE; GLUCOSE TOLERANCE; HIGH RISK POPULATION; HUMAN; INSULIN RELEASE; INSULIN SENSITIVITY; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; ORAL GLUCOSE TOLERANCE TEST; PREGNANCY DIABETES MELLITUS; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR;

ADULT; ALANINE TRANSAMINASE; DIABETES, GESTATIONAL; FATTY LIVER; FEMALE; HUMANS; PREGNANCY; PREVALENCE;

EID: 79953757603     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-010-2009-0     Document Type: Article

References (23)

1. Angulo P (2002) Nonalcoholic fatty liver disease. N Engl J Med 346:1221-1231
2. Targher G, Bertolini L, Padovani R et al (2007) Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care 30:1212-1218 (Pubitemid 46684650)
3. Postic C, Girard J (2008) Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J Clin Invest 118:829-838 (Pubitemid 351364588)
4. Pagano G, Pacini G, Musso G et al (2002) Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association. Hepatology 35:367-372 (Pubitemid 34106376)
5. Chitturi S, Abeygunasekera S, Farrell GC et al (2002) NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 35:373-379 (Pubitemid 34106377)
6. Musso G, Gambino R, Biroli G et al (2005) Hypoadiponectinemia predicts the severity of hepatic fibrosis and pancreatic beta-cell dysfunction in nondiabetic nonobese patients with nonalcoholic steatohepatitis. Am J Gastroenterol 100:2438-2446
7. Kim CH, Park JY, Lee KU, Kim JH, Kim HK (2008) Fatty liver is an independent risk factor for the development of type 2 diabetes in Korean adults. Diabet Med 25:476-481
8. Shibata M, Kihara Y, Taguchi M, Tashiro M, Otsuki M (2007) Nonalcoholic fatty liver disease is a risk factor for type 2 diabetes in middle-aged Japanese men. Diabetes Care 30:2940-2944 (Pubitemid 350083148)
9. Okamoto M, Takeda Y, Yoda Y, Kobayashi K, Fujino MA, Yamagata Z (2003) The association of fatty liver and diabetes risk. J Epidemiol 13:15-21 (Pubitemid 44137123)
10. O'Sullivan JB (1991) Diabetes mellitus after GDM. Diabetes 40 (Suppl 2):131-135
11. Yue DK, Molyneaux LM, Ross GP, Constantino MI, Child AG, Turtle JR (1996) Why does ethnicity affect prevalence of gestational diabetes? The underwater volcano theory. Diabet Med 13:748-752 (Pubitemid 26252955)
12. WHO (1999) Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation. WHO, Geneva
13. Sanyal AJ (2002) AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 123:1705-1725
14. O'Sullivan JB (1982) Body weight and subsequent diabetes mellitus. JAMA 248:949-952
15. Dornhorst A, Bailey PC, Anyaoku V, Elkeles RS, Johnston DG, Beard RW (1990) Abnormalities of glucose tolerance following gestational diabetes. Q J Med 77:1219-1228
16. Sattar N, Scherbakova O, Ford I et al (2004) Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the west of Scotland coronary prevention study. Diabetes 53:2855-2860 (Pubitemid 39425910)
17. Ohlson LO, Larsson B, Bjorntorp P et al (1988) Risk factors for type 2 (non-insulin-dependent) diabetes mellitus. Thirteen and one-half years of follow-up of the participants in a study of Swedish men born in 1913. Diabetologia 31:798-805
18. Andre P, Balkau B, Born C et al (2005) Hepatic markers and development of type 2 diabetes in middle aged men and women: a three-year follow-up study. The D.E.S.I.R. Study (Data from an Epidemiological Study on the Insulin Resistance syndrome). Diabetes Metab 31:542-550 (Pubitemid 43001171)
19. Nannipieri M, Gonzales C, Baldi S et al (2005) Liver enzymes, the metabolic syndrome, and incident diabetes: the Mexico City diabetes study. Diabetes Care 28:1757-1762 (Pubitemid 40923089)
20. Fraser A, Harris R, Sattar N, Ebrahim S, Davey Smith G, Lawlor DA (2009) Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: the British Women's Heart and Health Study and meta-analysis. Diabetes Care 32:741-750
21. Clark JM, Brancati FL, Diehl AM (2003) The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol 98:960-967 (Pubitemid 36733754)
22. Forbes S, Robinson S, Dungu J et al (2006) Sustained endogenous glucose production, diminished lipolysis and non-esterified fatty acid appearance and oxidation in non-obese women at high risk of type 2 diabetes. Eur J Endocrinol 155:469-476
23. Bedogni G, Gastaldelli A, Manco M et al (2010) Relationship between fatty liver and glucose metabolism: a cross-sectional study in 571 obese children. Nutr Metab Cardiovasc. doi:10.1016/j.numecd.2010.05.003